.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
UBS
Moodys
Daiichi Sankyo
McKesson
US Department of Justice
Express Scripts
Cipla
Johnson and Johnson
US Army

Generated: December 13, 2017

DrugPatentWatch Database Preview

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for albuterol sulfate; ipratropium bromide and what is the scope of albuterol sulfate; ipratropium bromide freedom to operate?

Albuterol sulfate; ipratropium bromide
is the generic ingredient in four branded drugs marketed by Boehringer Ingelheim, Apotex Inc, Cipla Ltd, Nephron, Ritedose Corp, Sandoz Inc, Sun Pharma Global, Teva Pharms, Watson Labs Teva, and Mylan Speciality Lp, and is included in eleven NDAs. There are eighteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Albuterol sulfate; ipratropium bromide has five hundred and two patent family members in forty-four countries.

There are thirty-seven drug master file entries for albuterol sulfate; ipratropium bromide. Sixteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Pharmacology for ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Tentative approvals for ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Applicant Application No. Strength Dosage Form
u► SubscribeEQ 0.083% BASE;0.017%SOLUTION;INHALATION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Sun Pharma GlobalALBUTEROL SULFATE AND IPRATROPIUM BROMIDEalbuterol sulfate; ipratropium bromideSOLUTION;INHALATION207875-001Aug 7, 2017ANRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ritedose CorpALBUTEROL SULFATE AND IPRATROPIUM BROMIDEalbuterol sulfate; ipratropium bromideSOLUTION;INHALATION202496-001Oct 1, 2012ANRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Sandoz IncALBUTEROL SULFATE AND IPRATROPIUM BROMIDEalbuterol sulfate; ipratropium bromideSOLUTION;INHALATION076867-001Dec 21, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Apotex IncALBUTEROL SULFATE AND IPRATROPIUM BROMIDEalbuterol sulfate; ipratropium bromideSOLUTION;INHALATION077117-001Dec 31, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: albuterol sulfate; ipratropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENTalbuterol sulfate; ipratropium bromideAEROSOL, METERED;INHALATION020291-001Oct 24, 1996► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011► Subscribe► Subscribe
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: albuterol sulfate; ipratropium bromide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,084,461Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease► Subscribe
6,497,373 Device for producing high pressure in a fluid in miniature► Subscribe
6,503,440 Process for making a container with a pressure equalization opening and containers produced accordingly► Subscribe
6,918,547 Device for producing high pressure in a fluid in miniature► Subscribe
7,451,884Container provided with a pressure equalization opening► Subscribe
6,402,055 Device for producing high pressure in a fluid in miniature► Subscribe
7,645,383Microstructured filter► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: albuterol sulfate; ipratropium bromide

Country Document Number Estimated Expiration
European Patent Office0853501► Subscribe
China1271296► Subscribe
Egypt22811► Subscribe
Japan4933252► Subscribe
CroatiaP980526► Subscribe
World Intellectual Property Organization (WIPO)9724586► Subscribe
World Intellectual Property Organization (WIPO)2004091536► Subscribe
Poland339492► Subscribe
Japan2007517646► Subscribe
China1341009► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Cerilliant
US Army
Express Scripts
Chubb
Farmers Insurance
Baxter
AstraZeneca
McKinsey
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot